Skip to main content
OpenTrials
Completed

NCT Number: NCT01054131

Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program

Inflammatory arthritis (IA) is a major cause of long-term disability. Peer support may be a solution to the common problem of delayed treatment. Early peer support may result in improved use of therapy, higher self-efficacy, reduced anxiety, and improved coping in the first two years post-diagnosis. The whole intervention study comprises of two parts: The first part involves the development and testing of a peer mentor training initiative, which is called "Peer to Peer Mentoring: Facilitating Individuals with Early Inflammatory Arthritis to Manage their Arthritis - Peer Mentor Training". The second part, which is the focus of this study, involves the delivery of a one-on-one peer support intervention from a trained peer mentor to an individual newly diagnosed with EIA. The feasibility and acceptability of the program will be determined, as well as the health outcomes following the participation of the program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Early Inflammatory Arthritis Arthritis Chronic Disease Disease Attributes Joint Diseases Musculoskeletal Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have EIA disease duration within 6-52 weeks
  • At least 3 swollen joints, assessed by the treating rheumatologist, OR positive compression test for the metacarpophalangeal joints OR positive compression test for the metatarsophalangeal joints OR at least 30 minutes of morning stiffness
  • Prescription of a DMARD/biologic by the treating rheumatologist
  • Ability to speak and understand English without the aid of a secondary support person; AND
  • Capability to provide informed consent.

Exclusion criteria

  • IA disease duration less than 6 weeks or greater than 1 year
  • Previous or ongoing DMARD or biologic treatment
  • Inability to speak or read grade 6 English; AND
  • Inability to provide informed consent

Treatment and study plan

Peer Support

Behavioral

A quasi-experimental, before and after study design will obtain data for planning and implementing a larger-scale study. Exposures and outcomes will be measured at baseline, 3 months (immediate post 12-week program) and 6 months (3 months post-program). Ten individuals with EIA will be recruited by brief screening interviews to ensure they meet inclusion criteria. Each pair of peer mentor and EIA participant will meet at SHSC for an initial contact. EIA participants will receive informational, emotional and appraisal support from trained peer mentors by telephone or neutral private location at a time convenient for both parties, at least once a week for 12 weeks.

Primary outcomes

  1. DMARD adherence

    Time frame: 0, 3, 6 months

Secondary outcomes

  1. coping efficacy

    Time frame: 0, 3 6 months

  2. self-management

    Time frame: 0, 3, 6 months

  3. anxiety

    Time frame: 0, 3, 6 months

  4. self efficacy

    Time frame: 0, 3, 6 months

  5. social support

    Time frame: 0, 3, 6 months

Sponsors and collaborators

Lead sponsor

Sunnybrook Health Sciences Centre

Other

Collaborators

  • Canadian Arthritis Network

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jan 22, 2010
Registry last updated
Dec 29, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.